Urinary tract infections;Harnwegsinfektionen

Internist

Volumn 52, Issue 9, 2011, Pages 1026-1031

  Horl W H ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Aminoglycosides; Antibiotic resistance; Escherichia coli; Mucoproteins; Toll like receptors

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CARBAPENEM; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; FOSFOMYCIN; PIPERACILLIN PLUS TAZOBACTAM; PIVMECILLINAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL VIRULENCE; COMMUNICABLE DISEASE; COMORBIDITY; CYSTITIS; DIABETES MELLITUS; ESCHERICHIA COLI; HOSPITAL INFECTION; HOST RESISTANCE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL NEPHRITIS; PYELONEPHRITIS; TREATMENT DURATION; URINARY TRACT INFECTION; UROSEPSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BIOLOGICAL AVAILABILITY; CROSS-SECTIONAL STUDIES; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY, COMBINATION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; MICE; OPPORTUNISTIC INFECTIONS; RISK FACTORS; TOLL-LIKE RECEPTORS; URINARY TRACT INFECTIONS; VIRULENCE FACTORS;

EID: 80054728818     PISSN: 00209554     EISSN: 14321289     Source Type: Journal    
DOI: 10.1007/s00108-011-2861-0     Document Type: Article

References (18)

1. Allison KR, Brynildsen M P, Collins JJ (2011) Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473:216-220
2. Andersen-Nissen E, Hawn TR, Smith KD et al (2007) Cutting edge: Tlr5-/- mice are more susceptible to Escherichia coli urinary tract infection. J Immunol 178:4717-4720 (Pubitemid 46595250)
3. Apfalter P, Fluch G, Oegger G (2009) Resistenzbericht Österreich AURES 2009. Bundesministerium für Gesundheit. http://www.ages.at/uploads/ me-dia/AURES-2009.pdf. Zugegriffen 03. August 2011
4. Bates JM, Raffi HM, Prasadan K et al (2004) Tamm-Horsfall protein knockout mice are more prone to urinary tract infection. Kidney Int 65:791-797 (Pubitemid 38251055)
5. Bleidorn J, Gagyor I, Kochen MM et al (2010) Symptomatic treatment (ibuprofen) or antibiotics (ci-profloxacin) for uncomplicated urinary tract infection? Results of a randomized controlled pilot trial. BMC 8:30
6. Butler CC, Dunstan F, Heginbothom M et al (2007) Containing antibiotic resistance: decreased antibiotic-resistant coliform urinary tract infections with reduction in antibiotic prescribing by general practices. Br J Gen Pract 57:785-793
7. Christiaens TC, De Meyere M, Verschraegen G et al (2002) Randomised controlled trial of nitrofuran-toin versus placebo in the treatment of uncomplicated urinary tract infection in adult women. Br J Gen Pract 52:729-734 (Pubitemid 36187595)
8. Dhakal BK, Kulesus RR, Mulvey MA (2008) Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli. Eur J Clin Invest 38(Suppl 2):2-11
9. Falagas ME, Kotsantis IK, Vouloumanou EK, Rafaili-dis PI (2009) Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials. J Infect 58:91-102
10. Ferry SA, Holm SE, Stenlund H et al (2007) Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project. Scand J Prim Health Care 25:49-57
11. Karlowsky JA, Lagace-Wiens PR, Simner JP et al (2011) Antimicrobial resistance in urinary tract pathogens in Canada from 2007-2009: CANWARD Surveillance Study. Antimicrob Agents Chemother 55:3169-3175
12. Little P, Turner S, Rumbsy K et al (2009) Dipsticks and diagnostic algorithms in urinary tract infection: development and validation, randomized trial, economic analysis, observational cohort and qualitative study. Health Technol Assess 13: iii-iv, ix-xi
13. Säemann MD, Weichert T, Zeyda M et al (2005) Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via Toll-like receptor-4 dependent mechanism. J Clin Invest 115:468-475 (Pubitemid 40385489)
14. Schmiemann G, Kniel E, Gebhardt K et al (2010) The diagnosis of urinary tract infection. Dtsch Arzt-ebl Int 107:361-367
15. Song J (2007) TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder. Cell Host Microbe 1:287-298 (Pubitemid 46865609)
16. Stein G, Fünfstück R (2008) Medikamentöse Therapie von Harnwegsinfekten. Internist 49:747-755
17. Wagenlehner FM, Weidner W, Naber KG (2007) Optimal management of urosepsis from urological perspective. Int J Antimicrob Agents 30:390-397 (Pubitemid 47498969)
18. Wagenlehner FM, Schmiemann G, Hoyme U et al (2011) Nationale S3-Leitlinie "Unkomplizierte Harnwegsinfektionen". Empfehlungen zu Therapie und Management unkomplizierter bakterieller ambulant erworbener Harnwegsinfektionen bei erwachsenen Patienten. Urologe 50:153-169